The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Momenta Pharmaceuticals Inc.  (MNTA) Trade Now »     Rate MNTA  -  Discuss MNTA  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate MNTA:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

MNTA: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Generic Drug Industry Outpaces Drug & Healthcare ETFs Graphic_rating_buy MNTA
Mikerun
73%

Generic Drug Industry Outpaces Drug & Healthcare ETFs

<>
The accompanying table presents statistics and the top five rated companies in the ETFI Global Generic Drug Index, which includes a total of 44 companies. Over the past year, generic drug companies have outpaced both the Healthcare Sector SPDR (XLV) and existing drug ETFs such as PowerShares Dynamic Pharma (PJP), Pharma HOLDRs (PPH), iShares Dow Jones US Pharma (IHE), and the S&P Pharma SPDR (XPH).

All of the top five rated generic drug companies and over two-thirds of the 44 companies in the index are b...
By  Mike Havrilla   (+1.04%  risk: conservative)  10/15/08 Comment


FDA Calendar: Near-Term Movers Graphic_rating_buy MNTA
Mikerun
73%

FDA Calendar of Decision Dates: Some Likely Near-Term Movers

<>
Some likely near-term movers on the FDA's decision date calendar for 70 different items (click to enlarge, left) include Cypress Bioscience ( CYPB ) + partner Forest Labs ( FRX ) with a pending decision on milnacipran in the treatment of fibromyalgia slated for the end of October in addition to results from a Phase 3 trial for the drug some time before year end.
<>
Also, Discovery Labs ( DSCO ) is not listed on the calendar, but expects to file a complete response to a May 1st FDA approvab...
By  Mike Havrilla   (+1.04%  risk: conservative)  10/10/08 Comment


A Waiting Game for Momenta Pharma Graphic_rating_buy MNTA
Mikerun
73%

A Waiting Game for Momenta Pharma

<>
According to a SEC 8-K filing today, an amendment has been submitted to the FDA for Momenta Pharma's (MNTA) Enoxaparin Sodium Injection Abbreviated New Drug Application [ANDA] by its partner, Sandoz, which is the generic drug operating division of Novartis (NVS). Momenta believes the amendment represents a complete response to the agency's concerns over the potential for immune-mediated reactions to the product, which is intended to be a generic equivalent of the injectable blood thinner Lovenox.

Momenta Pharma represe...
By  Mike Havrilla   (+1.04%  risk: conservative)  09/26/08 Comment


An Overview and Analysis of the Global Generic Drug Industry Graphic_rating_buy MNTA
Mikerun
73%

An Overview and Analysis of the Global Generic Drug Industry

<>
Global Generic Drug Industry: Benchmark Comps
Global Generic Drug Industry: Top 5 Companies by Market Cap


Global Generic Drugs: Top 5 Companies by Stock Performance

The accompanying tables provide a snapshot of my 38-company Global Generic Drug Index, which is rapidly consolidating amidst a flurry of recent M&A activity -- including the following buyout offers:
<> <> <> <> Industry leader Teva Pharma (TEVA): buyout bid...
By  Mike Havrilla   (+1.04%  risk: conservative)  08/15/08 Comment


Bullish on MNTA ... Graphic_rating_buy MNTA
Images
79%
general rule avoid spec btk. but since this is make believe
By  leo stotch   (+3.98%  risk: moderate)  04/28/08 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.25% 381
2 Gerald Greene 18.14 +72.34% 210
3 stockmarketfunding.com 17.66 +25.65% 55
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +76.91% 39


POPULAR STOCKS
Symbol Company Name Sentiment
INTC Intel Corp
T AT&T Inc
AMD Advanced Micro Devices Inc
BAC Bank of America Corp
C Citigroup Inc
RIO Companhia Vale Do Rio Doce

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on MNTA

Visit streetinsider.com


Discussion Wall + Add  
amritadas   (+0.00%)
A FREE report on upcoming FDA decision for small ca.. - FDA decision date coming up this month for small cap company's Pain drug. If the FDA approves the drug, the peak sales could reach over 200% of the com...
+   0 replies


More Resources

Graphic_arrow1 About Momenta Pharmaceuticals Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch